CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 676 | 763 | 88.6% | |
| CKD 5 | 2012 | 785 | 872 | 90.0% | |
| CKD 5 | 2013 | 724 | 805 | 89.9% | |
| CKD003 | 2014 | 732 | 789 | 92.8% | |
| CKD003 | 2015 | 755 | 817 | 92.4% | |
| NM84 | 2016 | 765 | 927 | 82.5% | |
| NM84 | 2018 | 471 | 605 | 77.9% | |
| NM84 | 2022 | 385 | 516 | 74.6% | |
| NM84 | 2023 | 379 | 508 | 74.6% |
